Hematologic Cancer and Benign Hematology Care Treatment

With a multidisciplinary approach that includes prevention, early detection, the use of standard and promising new therapies, participation in laboratory and clinical research, and extensive complementary care, the team at Hoag Family Cancer Institute provides cancer patients with every diagnostic and therapeutic advantage.

Winning Against Hematologic Malignancies

Hoag Family Cancer Institute provides treatment in the care of adult patients suffering from the various hematologic malignancies, including acute leukemia’s (myeloid and lymphoid), chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), Hodgkin’s Disease, Non-Hodgkin’s Lymphomas and multiple myeloma.

Offering Molecular Imaging Trial for Myeloma

Hoag was the first in the nation to open a phase 2 clinical trial using molecular imaging to sensitively detect myeloma, helping to provide important insight into treatment planning.

Learn More